Vor Biopharma Inc (VOR) — Defensive Interval Ratio

Latest as of December 2025: 852 days

Vor Biopharma Inc (VOR) has a Defensive Interval Ratio of 852 days as of December 2025. Defensive assets of $58.72 Million (cash $-, short-term investments $58.72 Million, receivables $-) cover 852 days of daily cash needs of $68.96K/day. Check Vor Biopharma Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

852 days
Days of operational coverage

Defensive Assets

$58.72 Million
Cash + ST Investments + Receivables

Daily Cash Need

$68.96K
Current Liabilities ÷ 365

Current Liabilities

$25.17 Million
USD

Vor Biopharma Inc Defensive Interval Ratio (2020–2025)

This chart shows how Vor Biopharma Inc's Defensive Interval Ratio has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the ratio stands at 852 days, meaning defensive assets of $58.72 Million can fund 852 days of operations without new revenue. Also explore Vor Biopharma Inc equity growth rate to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for Vor Biopharma Inc (2020–2025)

The table below presents the year-by-year Defensive Interval Ratio for Vor Biopharma Inc from 2020 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Vor Biopharma Inc market cap and net worth.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2025 852 days $58.72 Million $68.96K/day $- $58.72 Million ▲ +656 days
2024 196 days $9.98 Million $50.99K/day $- $9.98 Million ▼ -2285 days
2023 2480 days $105.81 Million $42.66K/day $- $105.81 Million ▼ -2320 days
2022 4800 days $172.54 Million $35.94K/day $- $172.54 Million ▲ +1649 days
2021 3152 days $87.67 Million $27.82K/day $- $87.67 Million ▲ +3152 days
2020 0 days $0.00 $27.96K/day $- $0.00
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)